How Ph.D. was paid
$879,248 in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Total |
|---|---|---|---|
| Jay M. Short, Ph.D.Chief Executive Officer, Co-founder, and Chairman of the Board of Directors | $734,820 | $144,428 | $879,248 |
| Richard A. WaldronChief Financial Officer | $485,450 | $30,730 | $516,180 |
| Eric Sievers, M.D.Chief Medical Officer | $530,630 | $53,778 | $584,408 |
What changed and why
- $879K$879,248 was the CEO’s 2025 total compensation, compared with $1,952,798 in 2024.
- $144K$144,428 was the CEO’s 2025 stock-award value, compared with $942,420 in 2024.
- $1.2M$1,235,507 was the CEO’s 2025 compensation actually paid under pay-versus-performance rules.
- $555K$555,106 was the average 2025 compensation actually paid to non-PEO named executives.
- 2025 CEO compensation included no reported option awards, non-equity incentive compensation, or other compensation.
- Dr. Sievers receives six months of salary continuation after a qualifying termination outside a change in control.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.